Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uro-Vaxom for prevention of recurrent symptomatic urinary tract infections in chronic neurogenic bladder dysfunction
ISRCTN11666384Phase 4Completed
- Sponsor
- Buckinghamshire Healthcare NHS Trust
- Start
- Aug 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, randomised, double-blind trial in urinary tract infection (UTI) comparing Uro-Vaxom with Placebo (2 arms). Primary endpoint: Study feasibility. Started Aug 2016; status: completed.
02
Drugs
OM-89
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ISRCTN11666384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11666384.